Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Discovery & Translation

Science Spotlight: Killing the mesenchymal precursors that drive cancer progression

BioCentury’s roundup of translational innovations also includes blood detection of pregnancy complications, BBB-crossing antibodies, and more

March 12, 2025 11:21 PM UTC

Selective ablation of cancer cells with a spindle-like morphology that undergo an epithelial-to-mesenchymal (EMT) transition could prevent pancreatic cancer progression, suggests a Nature study led by researchers at University of Texas MD Anderson Cancer Center.

Using lineage-tracing and a lineage-ablation system in a genetically engineered mosaic mouse model of pancreatic cancer, the authors identified and selectively targeted tumor cells derived from mesenchymal cancer cells, resulting in increased survival and decreased tumor growth and metastasis. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article